Approval in Myasthenia gravis in key markets could eventually ... open-label study which found benefits for patients with anti-AchR antibody-positive gMG who had previously failed ...
Like Soliris and Ultomiris, Zilbrysq is approved for use in adults with gMG who are anti-acetylcholine receptor (AChR) antibody ... chief executive of the Myasthenia Gravis Foundation of America.
Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today revealed that ...
FineHeart S.A., a clinical-stage medtech company developing breakthrough solutions for cardiology, announces the appointment of Sébastien Robitaille as Chief Financial Officer. Driven by the ...
Zacks Investment Research on MSN2d
AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease IndicationAmgen AMGN announced that the FDA has approved its rare disease drug Uplizna (inebilizumab) for a new indication. The ...
UCB, a global biopharmaceutical company, today announced it will present 24 abstracts from its expansive neurology portfolio, regarding rare epilepsies Dravet syndrome (DS) and Lennox-Gastaut syndrome ...
Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback